The FDA approved fremanezumab (Ajovy) to prevent migraines, the second drug in its class and the first that'll be available in quarterly and monthly dosing.

The FDA approved its final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) as part of the agency’s ongoing efforts to address the opioid crisis.

A large study suggests daily, low-dose aspirin does not prolong life or cut disability or dementia risk, and that it can raise the risk of bleeding.

Inhaled steroids to treat asthma, COPD, or another breathing problem increase the risk for nontuberculous mycobacteria (NTM) lung infections.

Some generic versions of a medication used to treat high blood pressure and heart failure, valsartan, don't meet FDA safety standards.

Learn about the origins of diabetes in history and how treatment has developed over the years and changed our modern understanding of the disease.

Have you or someone you know been diagnosed with ovarian cancer? Here’s what you should know about the latest therapies available.

Solriamfetol was initially developed as an antidepressant, but after patients saw an increase in wakefulness they thought, wait a second, would this help with sleep disorders such as narcolepsy? And they were right.

“Do I take it immediately? Do I double up? How will it be affected if I just ate or drank? Help!” We’ve got you covered.

It makes sense, really — sleep has a big influence on how hungry we feel and the type of food we choose to eat. So, when our sleep is erratic it can mess with our metabolism and urges to binge.